MYCN and acute lymphoblastic leukemia: These findings indicate that PNA-mediated transcriptional silencing of MYCN could significantly inhibit T-ALL cell growth both in vitro and on primary leukemic cells, which supports the role of MYCN as a target for therapy in T-ALL.